Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report)’s share price traded down 3.8% during trading on Friday . The stock traded as low as $45.12 and last traded at $45.12. 1,488 shares traded hands during mid-day trading, an increase of 114% from the average session volume of 695 shares. The stock had previously closed at $46.89.
Analyst Ratings Changes
Several equities analysts have commented on the company. The Goldman Sachs Group raised Pro Medicus from a “neutral” rating to a “buy” rating in a research report on Thursday, July 27th. Jefferies Financial Group initiated coverage on Pro Medicus in a research note on Thursday, June 29th. They set a “hold” rating for the company.
View Our Latest Stock Analysis on PMCUF
Pro Medicus Stock Performance
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.
Further Reading
- Five stocks we like better than Pro Medicus
- What Do S&P 500 Stocks Tell Investors About the Market?
- The Best 5 Small Cap AI Companies to Buy Now
- Transportation Stocks Investing
- Miso Robotics Stock: Is an IPO Coming Soon?
- What Are Growth Stocks and Investing in Them
- 3 Stocks to Play the Easing Food Supply Chain
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.